$4.69 Billion Verdict in Johnson & Johnson Baby Powder Talc Lawsuit is Upheld

talc

Despite arguments against doing so, a Missouri judge has decided in favor of people with ovarian cancer affected by Johnson & Johnson’s Baby Powder, upholding a remarkable $4.69 billion verdict delivered earlier this year by a St. Louis jury.

The judgment awarded $25 million to each of 22 women and their families after they agreed that the women’s cancer had been caused by asbestos that was hidden in the talc-based product. Legal experts say that the judge’s decision will encourage more women who have suffered as a result of exposure to the product to come forward and pursue their legal actions.

There have been a growing number of Johnson & Johnson’s Baby Powder talc lawsuits filed in recent days. The Missouri case specifically accused the company’s talc of being contaminated by asbestos, leading to ovarian cancer in women who used the product in their underwear or the genital area.

Six of the women named in that lawsuit have since died, and there are another 10,600 similar cases that are pending. There are also separate lawsuits that have accused the product of being responsible for their malignant mesothelioma.

Judge’s Decision Likely to Encourage Others to File Johnson & Johnson’s Talc Baby Powder Lawsuits

The lawsuits filed against Johnson & Johnson’s Talc Baby Powder argue that the product was contaminated by asbestos and that the asbestos is responsible for cell death and genetic mutations that have led to the growth of both ovarian cancer tumors and malignant mesothelioma tumors.

It is well known that talc, a mineral, is frequently found near deposits of asbestos and that as a result there is a very real risk of asbestos contaminating talc-based products. Though Johnson & Johnson argues that their product was safe and did not contain asbestos, evidence continues to be presented that it was present in the iconic consumer product.

Legal experts anticipate that as a result of the judge’s recent action there is a stronger likelihood that the pharmaceutical giant will settle future talc claims instead of continuing to defend themselves in court.

Author: Terri Oppenheimer

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.